Rheumatology Network's Top 5: July 23, 2022


Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 23, 2022.

Rheumatoid Arthritis Quiz: Cancer and RA Treatment

Patients with rheumatoid arthritis (RA) have a higher risk of cancer, but does treatment of rheumatoid arthritis affect that risk? Test your knowledge with this quiz.

Apremilast Use May Delay Initiation of Biologics in Psoriatic Arthritis

Treatment with apremilast was associated with extended time to biologic initiation when compared with treatment with methotrexate.

Rates of SLE in the US Rise Alongside Increasingly Diverse Population

Previous assessments of the prevalence of lupus were conducted in short periods of time, therefore limiting the insight into long-term trends and potential explanations for the observed patterns.

Off Target: The Long-Term Sequelae of Inadequate Disease Control in SLE

As treatment options expand in SLE with an increasing number of targeted therapeutics, we can be optimistic about the potential to improve disease outcomes.

Obesity Increases Risk of COVID-19 Hospitalization in Juvenile Patients

“Understanding the impact of COVID-19 infection on children and young people with RMDs is important to inform national protection, education (such as school attendance), and vaccination guidance."

Related Videos
© 2024 MJH Life Sciences

All rights reserved.